Whelan K - Search Results

1

Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease.

Benjamin JL, Hedin CR, Koutsoumpas A, Ng SC, McCarthy NE, Hart AL, Kamm MA, Sanderson JD, Knight SC, Forbes A, Stagg AJ, Whelan K, Lindsay JO. Benjamin JL, et al. Among authors: whelan k. Gut. 2011 Jul;60(7):923-9. doi: 10.1136/gut.2010.232025. Epub 2011 Jan 24. Gut. 2011. PMID: 21262918 Clinical Trial.

2

Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease.

Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, Rayment N, Kamm MA, Knight SC, Forbes A. Lindsay JO, et al. Among authors: whelan k. Gut. 2006 Mar;55(3):348-55. doi: 10.1136/gut.2005.074971. Epub 2005 Sep 14. Gut. 2006. PMID: 16162680 Free PMC article. Clinical Trial.

3

Enteral-tube-feeding diarrhoea: manipulating the colonic microbiota with probiotics and prebiotics.

Whelan K. Whelan K. Proc Nutr Soc. 2007 Aug;66(3):299-306. doi: 10.1017/S0029665107005551. Proc Nutr Soc. 2007. PMID: 17637081 Free article. Review.

4

Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.

Hedin C, Whelan K, Lindsay JO. Hedin C, et al. Among authors: whelan k. Proc Nutr Soc. 2007 Aug;66(3):307-15. doi: 10.1017/S0029665107005563. Proc Nutr Soc. 2007. PMID: 17637082 Review.

5

Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.

Parkes GC, Brostoff J, Whelan K, Sanderson JD. Parkes GC, et al. Among authors: whelan k. Am J Gastroenterol. 2008 Jun;103(6):1557-67. doi: 10.1111/j.1572-0241.2008.01869.x. Epub 2008 May 29. Am J Gastroenterol. 2008. PMID: 18513268 Review.

6

The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea.

Parkes GC, Sanderson JD, Whelan K. Parkes GC, et al. Among authors: whelan k. Lancet Infect Dis. 2009 Apr;9(4):237-44. doi: 10.1016/S1473-3099(09)70059-3. Lancet Infect Dis. 2009. PMID: 19324296 Review.

7

Etiology of perianal Crohn's disease: role of genetic, microbiological, and immunological factors.

Tozer PJ, Whelan K, Phillips RK, Hart AL. Tozer PJ, et al. Among authors: whelan k. Inflamm Bowel Dis. 2009 Oct;15(10):1591-8. doi: 10.1002/ibd.21026. Inflamm Bowel Dis. 2009. PMID: 19637358 Review.

8

Treating irritable bowel syndrome with probiotics: the evidence.

Parkes GC, Sanderson JD, Whelan K. Parkes GC, et al. Among authors: whelan k. Proc Nutr Soc. 2010 May;69(2):187-94. doi: 10.1017/S002966511000011X. Epub 2010 Mar 18. Proc Nutr Soc. 2010. PMID: 20236566 Free article. Review.

9

Probiotic and prebiotic use in patients with inflammatory bowel disease: a case-control study.

Hedin CR, Mullard M, Sharratt E, Jansen C, Sanderson JD, Shirlaw P, Howe LC, Djemal S, Stagg AJ, Lindsay JO, Whelan K. Hedin CR, et al. Among authors: whelan k. Inflamm Bowel Dis. 2010 Dec;16(12):2099-108. doi: 10.1002/ibd.21286. Inflamm Bowel Dis. 2010. PMID: 20848469

10

Faecal microbiota and short-chain fatty acids in patients receiving enteral nutrition with standard or fructo-oligosaccharides and fibre-enriched formulas.

Majid HA, Emery PW, Whelan K. Majid HA, et al. Among authors: whelan k. J Hum Nutr Diet. 2011 Jun;24(3):260-8. doi: 10.1111/j.1365-277X.2011.01154.x. Epub 2011 Mar 18. J Hum Nutr Diet. 2011. PMID: 21414042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

457 results

Search Page

Filters